Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
701 (USA) · Dr. Reyes
consented 2012-08-05
AEs
4
Serious
0
Dropout signal
–
Adverse events
mild
assessed
Mild ATRIOVENTRICULAR BLOCK SECOND DEGREE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-08-26 (study day 22.0); relationship: POSSIBLE
mild
assessed
Mild ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-08-07 (study day 3.0); relationship: POSSIBLE
moderate
assessed
Moderate ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-08-07 (study day 3.0); relationship: PROBABLE
mild
assessed
Mild ERYTHEMA — outcome: RECOVERED/RESOLVED; onset 2012-08-07 (study day 3.0); relationship: POSSIBLE
Data queries
No data queries.